Literature DB >> 25096478

Rheumatoid pleural effusion with nodular pleuritis. A rare presentation of rheumatoid arthritis.

H Emmungil1, F Yıldız, M Y Gözükara, A Açıkalın.   

Abstract

Rheumatoid pleural effusion and lung nodules are unusual complications of rheumatoid disease that typically present subsequently to other more common manifestations of rheumatoid illness. However, these complications may occasionally occur before or concurrently with the development of joint manifestations of disease. We report the case of a 41-year-old female patient with rheumatoid pleural effusion and lung nodule arising simultaneously with the onset of joint symptoms. The patient underwent thoracentesis followed by video-assisted thoracoscopic biopsy to result in a diagnosis of rheumatoid pleuritis and nodular disease. A high index of suspicion and coexistence of the cytologic and histopathologic effusion picture characteristic of rheumatoid pleuritis are of clinical importance in making a diagnosis.

Entities:  

Mesh:

Year:  2015        PMID: 25096478     DOI: 10.1007/s00393-014-1462-4

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  14 in total

1.  Secondary spontaneous pneumothorax in a patient with pulmonary rheumatoid nodules during treatment with methotrexate.

Authors:  I Gotsman; A Goral; S Nusair
Journal:  Rheumatology (Oxford)       Date:  2001-03       Impact factor: 7.580

2.  2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative.

Authors:  Daniel Aletaha; Tuhina Neogi; Alan J Silman; Julia Funovits; David T Felson; Clifton O Bingham; Neal S Birnbaum; Gerd R Burmester; Vivian P Bykerk; Marc D Cohen; Bernard Combe; Karen H Costenbader; Maxime Dougados; Paul Emery; Gianfranco Ferraccioli; Johanna M W Hazes; Kathryn Hobbs; Tom W J Huizinga; Arthur Kavanaugh; Jonathan Kay; Tore K Kvien; Timothy Laing; Philip Mease; Henri A Ménard; Larry W Moreland; Raymond L Naden; Theodore Pincus; Josef S Smolen; Ewa Stanislawska-Biernat; Deborah Symmons; Paul P Tak; Katherine S Upchurch; Jirí Vencovský; Frederick Wolfe; Gillian Hawker
Journal:  Arthritis Rheum       Date:  2010-09

Review 3.  The pathognomonic cytologic picture of rheumatoid pleuritis. The 1989 Maurice Goldblatt Cytology award lecture.

Authors:  B Naylor
Journal:  Acta Cytol       Date:  1990 Jul-Aug       Impact factor: 2.319

4.  Immunohistology of rheumatoid nodules and rheumatoid synovium.

Authors:  N A Athanasou; J Quinn; C G Woods; J O Mcgee
Journal:  Ann Rheum Dis       Date:  1988-05       Impact factor: 19.103

5.  Pulmonary lesions and rheumatoid arthritis.

Authors:  W C Walker; V Wright
Journal:  Medicine (Baltimore)       Date:  1968-11       Impact factor: 1.889

6.  Rheumatoid pleuritis.

Authors:  W C Walker; V Wright
Journal:  Ann Rheum Dis       Date:  1967-11       Impact factor: 19.103

Review 7.  Rheumatoid pleural effusion.

Authors:  Alexandra Balbir-Gurman; Mordechai Yigla; Abraham Menahem Nahir; Yolanda Braun-Moscovici
Journal:  Semin Arthritis Rheum       Date:  2006-06       Impact factor: 5.532

Review 8.  Pulmonary manifestations of rheumatoid arthritis.

Authors:  Danielle Antin-Ozerkis; Janine Evans; Ami Rubinowitz; Robert J Homer; Richard A Matthay
Journal:  Clin Chest Med       Date:  2010-09       Impact factor: 2.878

Review 9.  A simultaneous onset of organizing pneumonia and rheumatoid arthritis, along with a review of the literature.

Authors:  Shunsuke Mori; Isamu Cho; Yukinori Koga; Mineharu Sugimoto
Journal:  Mod Rheumatol       Date:  2007-12-26       Impact factor: 3.023

Review 10.  Pulmonary manifestations of rheumatoid arthritis.

Authors:  L T Tanoue
Journal:  Clin Chest Med       Date:  1998-12       Impact factor: 2.878

View more
  1 in total

1.  Osteoporosis in patients with rheumatoid arthritis is associated with serum immune regulatory cellular factors.

Authors:  Jianjun Qiu; Chunde Lu; Lei Zhang; Xu Zhou; Hanlin Zou
Journal:  Clin Rheumatol       Date:  2022-06-07       Impact factor: 3.650

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.